West Pharmaceutical Services, Inc. announced the opening of its new building at its current site in Damastown, Dublin. The 165,000 square foot expansion significantly enhances West's contract services and is designed to meet growing global demands of its customers' high-volume treatments, including diabetes and obesity. The Damastown expansion enhances West's contract capabilities beyond its component molding, device assembly, and packaging to now include advanced automation and expanded drug-handling capabilities at commercial scale.
The work at this site is part of West Vantage, the company's comprehensive contract services business. West Vantage provides customers with a single-source solution spanning product conceptualization, development, device manufacturing and assembly, packaging, validation, analytical testing, and regulatory support. Through this integrated approach, West helps pharmaceutical and biotechnology partners accelerate time to market by delivering reliable, scalable solutions that support the global supply of life-enhancing and life-saving therapies.
